HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome

Transplantation

Volumn 65, Issue 5, 1998, Pages 648-653

  Sundaresan, Sudhir ^a,b   Mohanakumar, T ^a   Smith, Michael A ^a   Trulock, Elbert P ^a   Lynch, John ^a   Phelan, Donna ^c   Cooper, Joel D ^a   Patterson, G Alexander ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Cardiothoracic Surgery   (United States)

^c BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA ANTIBODY;

ADULT; ARTICLE; BRONCHIOLITIS; FEMALE; FORCED EXPIRATORY VOLUME; HLA MATCHING; HLA SYSTEM; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; SPIROMETRY; SURVIVAL;

ADULT; AGE FACTORS; BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA-A ANTIGENS; HUMANS; ISOANTIBODIES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0032521298     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199803150-00008     Document Type: Article

References (25)

1. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713.
2. Rabinowich H, Zeevi A, Paradis IL, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990; 49: 115.
3. Scott JP, Higenbottam TW, Sharpies L, et al. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation 1991; 51: 813.
4. Yousem SA, Danker JA, Keenan R, Paradis IL, Zeevi A, Griffith BP. Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52: 306.
5. Burke CM, Glanville AR, Theodore J, Robin ED. Lung immunogenicity, rejection, and obliterative bronchiolitis. Chest 1987; 92: 547.
6. Yousem SA, Paradis IL, Danker JH, et al. Pulmonary arteriosclerosis in long-term human heart-lung transplant recipients. Transplantation 1989; 47: 564-569.
7. Burke CM, Glanville AR, Macoviak JA, et al. The spectrum of cytomegalovirus infection following human heart-lung transplantation. J Heart Transplant 1986; 5(4): 267.
8. Keenan RJ, Legn ME, Dummer JS, et al. Cytomegalovirus sero-logic status and post-operative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 1991; 51: 433.
9. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA, The Washington University Lung Transplant Group. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 1995; 60: 1341.
10. Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56: 1409.
11. Cooper JD, Pearson FG, Patterson GA, et al. Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg 1987; 93: 173.
12. Patterson GA, Cooper JD, Goldman B, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988; 45: 625.
13. Pasque MK, Cooper JD, Kaiser LR, Haydock DA, Triantafillou A, Trulock EP. Improved technique for bilateral lung transplantation: rationale and initial clinical experience. Ann Thorac Surg 1990; 49: 785.
14. Trulock EP. Management of lung transplant rejection. Chest 1993; 103: 1566.
15. Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest 1992; 102: 1049.
16. Kaplan EL, Meier EP. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
17. Harjula AL, Baldwin JC, Glanville AR, et al. Human leukocyte antigen compatibility in heart-lung transplantation. J Heart Transplant 1987; 6: 162.
18. Wisser W, Wekerle T, Zlabinger G, et al. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation. J Heart Lung Transplant 1996; 15: 1209.
19. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM III. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114: 195.
20. Suciu-Foca N, Reed E, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716.
21. Barr ML, Cohen DJ, Benvenisty AI, et al. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplantation Proc 1993; 25: 262.
22. Rizzo M, Sundaresan S, Lynch J, et al. Increased concentration of soluble human leukocyte antigen class I levels in bronchoalveolar lavage of human pulmonary allograft. J Heart Lung Transplant 1997; 16: 1135.
23. Puppo F, Scudeletti M, Indiveri F, Femme S. Serum HLA class I antigens: markers and modulators of an immune response. Immunol Today 1995; 16: 124.
24. Gammie JS, Pham SM, Colson YL, et al. Influence of panel-reactive antibody on survival and rejection after lung transplantation. J Heart Lung Transplant 1997; 16: 408.
25. Pirsch JD, D'Allessandro AM, Sollinger HW, et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53: 55.